BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 28434260)

  • 1. Dapsone-associated fixed drug eruption.
    Garcia D; Cohen PR
    Expert Rev Clin Pharmacol; 2017 Jul; 10(7):717-725. PubMed ID: 28434260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic, pharmacokinetic, and toxicological issues surrounding dapsone.
    Molinelli E; Paolinelli M; Campanati A; Brisigotti V; Offidani A
    Expert Opin Drug Metab Toxicol; 2019 May; 15(5):367-379. PubMed ID: 30943794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute Generalized Exanthematous Pustulosis (AGEP) due to dapsone in a patient with leprosy.
    Narasimharao P; Pratap DV; Suneetha S
    Lepr Rev; 2009 Mar; 80(1):81-4. PubMed ID: 19472855
    [No Abstract]   [Full Text] [Related]  

  • 4. A double blow for a patient with leprosy: a reversal reaction and an adverse drug reaction.
    Thangaraju P; Venkatesan S
    Lancet; 2019 Oct; 394(10207):1450. PubMed ID: 31631856
    [No Abstract]   [Full Text] [Related]  

  • 5. Dapsone induced acute photosensitivity dermatitis; a case report and review of literature.
    De D; Dogra S; Kaur I
    Lepr Rev; 2007 Dec; 78(4):401-4. PubMed ID: 18309716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dapsone-induced photosensitivity: a rare clinical presentation.
    Kar BR
    Photodermatol Photoimmunol Photomed; 2008 Oct; 24(5):270-1. PubMed ID: 18811870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
    Sapkota BR; Shrestha K; Pandey B; Walker SL
    Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dapsone and sulfapyridine.
    Paniker U; Levine N
    Dermatol Clin; 2001 Jan; 19(1):79-86, viii. PubMed ID: 11155588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Review on Dapsone Hypersensitivity Syndrome Among Chinese Patients with an Emphasis on Preventing Adverse Drug Reactions with Genetic Testing.
    Wang N; Parimi L; Liu H; Zhang F
    Am J Trop Med Hyg; 2017 May; 96(5):1014-1018. PubMed ID: 28167593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypersensitivity reactions to dapsone: a systematic review.
    Lorenz M; Wozel G; Schmitt J
    Acta Derm Venereol; 2012 Mar; 92(2):194-9. PubMed ID: 22307940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatal dapsone hypersensitivity syndrome with hypothyroidism and steroid-induced diabetes mellitus.
    Pai S; Munshi R; Nayak C
    Indian J Pharmacol; 2017; 49(5):396-398. PubMed ID: 29515281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality due to dapsone hypersensitivity syndrome complicating multi-drug therapy for leprosy in Nepal.
    Pandey B; Shrestha K; Lewis J; Hawksworth RA; Walker SL
    Trop Doct; 2007 Jul; 37(3):162-3. PubMed ID: 17716505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fixed genital drug eruption due to dapsone. A case report.
    Sinha MR
    Lepr India; 1982 Jan; 54(1):152-4. PubMed ID: 6212718
    [No Abstract]   [Full Text] [Related]  

  • 14. Renal hypersensitivity vasculitis associated with dapsone.
    Alves-Rodrigues EN; Ribeiro LC; Silva MD; Takiuchi A; Rabel-Filho OC; Martini-Filho D; Fontes CJ
    Am J Kidney Dis; 2005 Oct; 46(4):e51-3. PubMed ID: 16183407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dapsone 7.5% Gel: A Review in Acne Vulgaris.
    Al-Salama ZT; Deeks ED
    Am J Clin Dermatol; 2017 Feb; 18(1):139-145. PubMed ID: 28005194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary tract carcinoma in leprosy patients treated with dapsone for a long period.
    Hironaka K; Mizushima M; Tsuzi C; Makino H
    Nephron; 1997; 76(3):358-9. PubMed ID: 9226243
    [No Abstract]   [Full Text] [Related]  

  • 17. Dapsone-induced erythema multiforme with neutropenia in a patient with linear IgA dermatosis: case report and review of the literature.
    Urosevic-Maiwald M; Kerl K; Harr T; Bogdan Allemann I
    Int J Dermatol; 2013 Nov; 52(11):1369-71. PubMed ID: 23829595
    [No Abstract]   [Full Text] [Related]  

  • 18. The Function of HLA-B*13:01 Involved in the Pathomechanism of Dapsone-Induced Severe Cutaneous Adverse Reactions.
    Chen WT; Wang CW; Lu CW; Chen CB; Lee HE; Hung SI; Choon SE; Yang CH; Liu MT; Chen TJ; Fan WL; Su SC; Lin YY; Chang YC; Chung WH;
    J Invest Dermatol; 2018 Jul; 138(7):1546-1554. PubMed ID: 29458119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Onset Dapsone-induced Photosensitive Dermatitis: A Rare Side Effect of a Common Drug.
    Karjigi S; Murthy SC; Kallappa H; Kusuma MR; Reddy YN
    Indian J Lepr; 2015; 87(3):161-4. PubMed ID: 26999988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dapsone hypersensitivity syndrome in non-leprosy patients: a retrospective study of its incidence in a tertiary referral center in Taiwan.
    Sheen YS; Chu CY; Wang SH; Tsai TF
    J Dermatolog Treat; 2009; 20(6):340-3. PubMed ID: 19954390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.